Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
CEO Crisis Action Plan: Next 48 Hours Guiding Principles: Patient safety first. Regulatory compliance is non-negotiable. Transparency protects long-term enterprise value. Delaying disclosure of a serious, unexpected adverse event increases legal, financial, and reputational risk exponentially.Read the full answer